1. Home
  2. PPL vs WAT Comparison

PPL vs WAT Comparison

Compare PPL & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PPL Corporation

PPL

PPL Corporation

HOLD

Current Price

$34.39

Market Cap

24.8B

Sector

Utilities

ML Signal

HOLD

Logo Waters Corporation

WAT

Waters Corporation

HOLD

Current Price

$374.13

Market Cap

22.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPL
WAT
Founded
1920
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Laboratory Analytical Instruments
Sector
Utilities
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.8B
22.5B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
PPL
WAT
Price
$34.39
$374.13
Analyst Decision
Buy
Buy
Analyst Count
8
15
Target Price
$40.75
$390.67
AVG Volume (30 Days)
7.3M
632.3K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
3.18%
N/A
EPS Growth
32.44
3.82
EPS
1.47
10.88
Revenue
$8,979,000,000.00
$3,105,638,000.00
Revenue This Year
$7.55
$7.96
Revenue Next Year
$5.11
$6.32
P/E Ratio
$23.32
$34.76
Revenue Growth
8.42
6.90
52 Week Low
$31.22
$275.05
52 Week High
$38.27
$423.56

Technical Indicators

Market Signals
Indicator
PPL
WAT
Relative Strength Index (RSI) 43.14 42.31
Support Level $33.86 $372.93
Resistance Level $34.33 $397.55
Average True Range (ATR) 0.54 9.27
MACD 0.08 -4.19
Stochastic Oscillator 44.04 6.20

Price Performance

Historical Comparison
PPL
WAT

About PPL PPL Corporation

PPL is a holding company of regulated utilities in Pennsylvania, Kentucky, and Rhode Island. The Pennsylvania regulated delivery and transmission segment distributes electricity to customers in central and eastern Pennsylvania. In Kentucky, LG&E and KU are involved in regulated electricity generation, transmission, and distribution. LG&E also provides regulated natural gas distribution. Rhode Island Energy operates electric and gas utilities in the state.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: